Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Kawasumi Laboratories Inc Amends Mid-year Consolidated Outlook for FY 2013

Friday, 26 Oct 2012 04:00am EDT 

Kawasumi Laboratories Inc announced that it has lowered its mid-year consolidated outlook for revenue from JPY 13,300 million to JPY 13.000 million, operating profit from JPY 350 million to JPY 100 million, ordinary profit from JPY 220 million to JPY 180 million, and raised its mid-year consolidated outlook for net profit (loss) from JPY (420 million) to JPY (400 million), and earnings (loss) per share from JPY (18.40) to JPY (17.43), for the fiscal year ending March 31, 2013. 

Company Quote

5.0 +0.65%
19 Sep 2014